Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroconvulsive Therapy | 17 | 2024 | 506 | 3.570 |
Why?
|
Psychomotor Agitation | 16 | 2024 | 304 | 3.460 |
Why?
|
Geriatric Psychiatry | 13 | 2021 | 70 | 3.330 |
Why?
|
Dementia | 23 | 2024 | 2744 | 2.970 |
Why?
|
Bipolar Disorder | 35 | 2024 | 5138 | 2.780 |
Why?
|
Alzheimer Disease | 20 | 2023 | 8730 | 1.540 |
Why?
|
Mood Disorders | 3 | 2024 | 1128 | 1.410 |
Why?
|
Antipsychotic Agents | 10 | 2022 | 3076 | 1.380 |
Why?
|
Antimanic Agents | 4 | 2018 | 523 | 1.350 |
Why?
|
Depressive Disorder, Major | 21 | 2024 | 4808 | 1.310 |
Why?
|
Spirituality | 6 | 2024 | 430 | 1.300 |
Why?
|
Aging | 23 | 2024 | 8731 | 1.180 |
Why?
|
Antidepressive Agents | 9 | 2020 | 2897 | 0.990 |
Why?
|
Religion | 5 | 2024 | 376 | 0.920 |
Why?
|
Mental Disorders | 12 | 2021 | 6853 | 0.910 |
Why?
|
Aggression | 8 | 2022 | 748 | 0.910 |
Why?
|
Ubiquinone | 2 | 2015 | 181 | 0.790 |
Why?
|
Aspartic Acid | 2 | 2019 | 576 | 0.790 |
Why?
|
Magnetic Resonance Spectroscopy | 9 | 2021 | 3672 | 0.750 |
Why?
|
Coronavirus Infections | 6 | 2020 | 3100 | 0.750 |
Why?
|
Pneumonia, Viral | 6 | 2020 | 3223 | 0.750 |
Why?
|
Long-Term Care | 2 | 2020 | 629 | 0.710 |
Why?
|
Caregivers | 7 | 2023 | 2307 | 0.700 |
Why?
|
Energy Metabolism | 7 | 2021 | 2892 | 0.650 |
Why?
|
Aged | 78 | 2024 | 171117 | 0.630 |
Why?
|
Lithium Compounds | 5 | 2022 | 226 | 0.620 |
Why?
|
Inpatients | 2 | 2021 | 2564 | 0.610 |
Why?
|
Neuropsychological Tests | 9 | 2024 | 7123 | 0.610 |
Why?
|
Pandemics | 6 | 2020 | 8703 | 0.610 |
Why?
|
Psychiatric Department, Hospital | 1 | 2018 | 134 | 0.590 |
Why?
|
Depressive Disorder | 4 | 2021 | 3714 | 0.560 |
Why?
|
Organizational Innovation | 1 | 2020 | 541 | 0.550 |
Why?
|
Citalopram | 2 | 2020 | 402 | 0.550 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2021 | 6014 | 0.510 |
Why?
|
Adaptation, Psychological | 3 | 2024 | 2660 | 0.490 |
Why?
|
Phosphocreatine | 1 | 2016 | 258 | 0.480 |
Why?
|
Humans | 140 | 2024 | 765968 | 0.480 |
Why?
|
Movement | 2 | 2019 | 1462 | 0.480 |
Why?
|
Religion and Psychology | 3 | 2024 | 179 | 0.470 |
Why?
|
Valproic Acid | 3 | 2017 | 445 | 0.460 |
Why?
|
Pharmacogenetics | 5 | 2020 | 682 | 0.440 |
Why?
|
Cognition Disorders | 3 | 2020 | 3967 | 0.440 |
Why?
|
Health Services Needs and Demand | 2 | 2020 | 1406 | 0.420 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.420 |
Why?
|
Brain | 10 | 2024 | 27171 | 0.410 |
Why?
|
Memory | 2 | 2020 | 2190 | 0.410 |
Why?
|
Geriatric Assessment | 5 | 2017 | 1429 | 0.400 |
Why?
|
Psychotic Disorders | 7 | 2021 | 3270 | 0.400 |
Why?
|
Psychotropic Drugs | 6 | 2020 | 879 | 0.390 |
Why?
|
Phosphates | 1 | 2016 | 763 | 0.390 |
Why?
|
Assisted Living Facilities | 2 | 2014 | 27 | 0.380 |
Why?
|
Hospice Care | 1 | 2018 | 678 | 0.380 |
Why?
|
Organophosphorus Compounds | 1 | 2013 | 209 | 0.380 |
Why?
|
Suicide | 1 | 2022 | 1604 | 0.360 |
Why?
|
Affective Symptoms | 1 | 2013 | 417 | 0.360 |
Why?
|
Primary Health Care | 5 | 2023 | 4736 | 0.350 |
Why?
|
Mental Health | 7 | 2023 | 3278 | 0.350 |
Why?
|
Sertraline | 2 | 2021 | 209 | 0.340 |
Why?
|
Creatine Kinase | 1 | 2012 | 682 | 0.340 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1470 | 0.330 |
Why?
|
Affect | 4 | 2023 | 1500 | 0.330 |
Why?
|
Adenosine Triphosphate | 1 | 2016 | 1999 | 0.330 |
Why?
|
Lithium Carbonate | 2 | 2016 | 179 | 0.320 |
Why?
|
Curriculum | 3 | 2021 | 3782 | 0.320 |
Why?
|
Home Care Services | 1 | 2015 | 660 | 0.310 |
Why?
|
Drug Utilization | 1 | 2015 | 1187 | 0.310 |
Why?
|
Male | 62 | 2024 | 363698 | 0.310 |
Why?
|
Cognition | 15 | 2023 | 7049 | 0.310 |
Why?
|
Aged, 80 and over | 21 | 2023 | 59489 | 0.300 |
Why?
|
Patient Care Team | 1 | 2019 | 2517 | 0.290 |
Why?
|
Inositol | 1 | 2008 | 215 | 0.290 |
Why?
|
Health Services for the Aged | 2 | 2020 | 265 | 0.280 |
Why?
|
Female | 61 | 2024 | 396112 | 0.280 |
Why?
|
Executive Function | 1 | 2016 | 1391 | 0.280 |
Why?
|
Ketamine | 2 | 2023 | 525 | 0.280 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8041 | 0.280 |
Why?
|
Health Care Costs | 1 | 2019 | 3242 | 0.260 |
Why?
|
Phospholipids | 1 | 2010 | 776 | 0.260 |
Why?
|
Depression | 5 | 2023 | 8237 | 0.260 |
Why?
|
Middle Aged | 45 | 2024 | 223009 | 0.250 |
Why?
|
Referral and Consultation | 1 | 2018 | 3615 | 0.250 |
Why?
|
Brain Diseases | 1 | 2014 | 1546 | 0.240 |
Why?
|
Treatment Outcome | 21 | 2024 | 65188 | 0.240 |
Why?
|
Facial Expression | 2 | 2019 | 516 | 0.240 |
Why?
|
Lithium | 3 | 2023 | 597 | 0.230 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3413 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2023 | 10383 | 0.230 |
Why?
|
Treatment Failure | 2 | 2020 | 2652 | 0.220 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5767 | 0.220 |
Why?
|
Single-Blind Method | 2 | 2024 | 1589 | 0.210 |
Why?
|
Fellowships and Scholarships | 3 | 2021 | 1135 | 0.210 |
Why?
|
Patient Preference | 3 | 2023 | 952 | 0.200 |
Why?
|
Education, Nursing | 1 | 2023 | 84 | 0.200 |
Why?
|
Mental Recall | 2 | 2020 | 1218 | 0.200 |
Why?
|
Financing, Organized | 1 | 2023 | 201 | 0.190 |
Why?
|
Psychotherapy | 3 | 2021 | 1645 | 0.190 |
Why?
|
Health Services | 2 | 2023 | 756 | 0.180 |
Why?
|
Mental Health Services | 4 | 2021 | 1723 | 0.180 |
Why?
|
Radio Frequency Identification Device | 1 | 2020 | 24 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36532 | 0.170 |
Why?
|
Phosphorus Isotopes | 2 | 2010 | 125 | 0.170 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2020 | 117 | 0.170 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2020 | 108 | 0.170 |
Why?
|
Hospitalization | 2 | 2018 | 10808 | 0.160 |
Why?
|
Remote Sensing Technology | 1 | 2020 | 93 | 0.160 |
Why?
|
Students, Medical | 3 | 2021 | 1959 | 0.160 |
Why?
|
Expert Testimony | 1 | 2020 | 266 | 0.150 |
Why?
|
Registries | 1 | 2015 | 8297 | 0.150 |
Why?
|
Double-Blind Method | 7 | 2021 | 12437 | 0.150 |
Why?
|
Cannabinoids | 1 | 2021 | 174 | 0.150 |
Why?
|
Civil Defense | 1 | 2020 | 114 | 0.150 |
Why?
|
Personnel Selection | 1 | 2020 | 201 | 0.150 |
Why?
|
Disease Progression | 2 | 2021 | 13632 | 0.150 |
Why?
|
Accreditation | 2 | 2021 | 477 | 0.140 |
Why?
|
Psychological Techniques | 1 | 2017 | 49 | 0.140 |
Why?
|
Drug Substitution | 1 | 2020 | 292 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2020 | 22223 | 0.140 |
Why?
|
Activities of Daily Living | 6 | 2023 | 2415 | 0.140 |
Why?
|
Narration | 1 | 2019 | 223 | 0.140 |
Why?
|
Emotions | 2 | 2019 | 2763 | 0.140 |
Why?
|
Creatine | 1 | 2019 | 424 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2017 | 6309 | 0.140 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 26318 | 0.130 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1731 | 0.130 |
Why?
|
Glutamine | 1 | 2019 | 576 | 0.130 |
Why?
|
Age Factors | 7 | 2019 | 18380 | 0.120 |
Why?
|
Comorbidity | 4 | 2024 | 10563 | 0.120 |
Why?
|
Spectrum Analysis | 1 | 2017 | 443 | 0.120 |
Why?
|
Placebos | 2 | 1999 | 1659 | 0.120 |
Why?
|
Delivery of Health Care | 3 | 2021 | 5370 | 0.120 |
Why?
|
Memory Disorders | 2 | 2020 | 1194 | 0.120 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2010 | 2477 | 0.120 |
Why?
|
Spiritual Therapies | 1 | 2015 | 60 | 0.120 |
Why?
|
Disaster Medicine | 1 | 2015 | 75 | 0.110 |
Why?
|
Psychiatry | 2 | 2014 | 1714 | 0.110 |
Why?
|
Suicidal Ideation | 2 | 2022 | 1461 | 0.110 |
Why?
|
Clinical Clerkship | 1 | 2020 | 568 | 0.110 |
Why?
|
Tai Ji | 1 | 2017 | 289 | 0.110 |
Why?
|
Adult | 22 | 2024 | 223044 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1394 | 0.110 |
Why?
|
Education, Medical, Graduate | 3 | 2021 | 2418 | 0.110 |
Why?
|
Pilot Projects | 3 | 2021 | 8733 | 0.110 |
Why?
|
Glycerylphosphorylcholine | 1 | 2013 | 25 | 0.110 |
Why?
|
Internship and Residency | 3 | 2021 | 5946 | 0.110 |
Why?
|
Glutamic Acid | 1 | 2019 | 1180 | 0.100 |
Why?
|
Delirium | 2 | 2022 | 1707 | 0.100 |
Why?
|
Research Design | 2 | 2019 | 6209 | 0.100 |
Why?
|
Telemedicine | 2 | 2020 | 3105 | 0.100 |
Why?
|
Alcoholism | 1 | 2023 | 1975 | 0.100 |
Why?
|
Phosphatidylethanolamines | 1 | 2013 | 128 | 0.100 |
Why?
|
Ethanolamines | 1 | 2013 | 152 | 0.100 |
Why?
|
Phosphorylcholine | 1 | 2013 | 151 | 0.100 |
Why?
|
Behavioral Symptoms | 2 | 2020 | 187 | 0.100 |
Why?
|
Demography | 3 | 2023 | 1641 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1792 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2021 | 1087 | 0.100 |
Why?
|
Education, Medical, Undergraduate | 1 | 2021 | 1085 | 0.100 |
Why?
|
Mitochondria | 3 | 2021 | 3673 | 0.100 |
Why?
|
Preventive Medicine | 1 | 2013 | 246 | 0.090 |
Why?
|
Policy Making | 1 | 2015 | 546 | 0.090 |
Why?
|
Retrospective Studies | 10 | 2023 | 81514 | 0.090 |
Why?
|
Sex Characteristics | 2 | 2023 | 2643 | 0.090 |
Why?
|
Psychometrics | 2 | 2019 | 3062 | 0.090 |
Why?
|
Anxiety Disorders | 2 | 2019 | 2737 | 0.090 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 721 | 0.090 |
Why?
|
Young Adult | 8 | 2021 | 59889 | 0.090 |
Why?
|
Geriatrics | 1 | 2015 | 396 | 0.090 |
Why?
|
Practice Guidelines as Topic | 3 | 2023 | 7425 | 0.090 |
Why?
|
Anxiety | 3 | 2020 | 4671 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3202 | 0.090 |
Why?
|
Drug Resistance | 1 | 2016 | 1591 | 0.090 |
Why?
|
Data Collection | 3 | 2023 | 3318 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2780 | 0.080 |
Why?
|
Sex Factors | 7 | 2024 | 10603 | 0.080 |
Why?
|
Psychotherapy, Group | 1 | 1993 | 416 | 0.080 |
Why?
|
Chronic Disease | 3 | 2019 | 9347 | 0.080 |
Why?
|
Independent Living | 1 | 2014 | 585 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15880 | 0.080 |
Why?
|
Specialization | 1 | 2014 | 777 | 0.080 |
Why?
|
Linear Models | 2 | 2010 | 5876 | 0.080 |
Why?
|
Frontal Lobe | 2 | 2021 | 1410 | 0.080 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3230 | 0.080 |
Why?
|
Social Participation | 2 | 2021 | 187 | 0.080 |
Why?
|
Medicine | 1 | 2017 | 942 | 0.080 |
Why?
|
Schizophrenia | 4 | 2018 | 6972 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1462 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4255 | 0.070 |
Why?
|
Social Adjustment | 1 | 2010 | 633 | 0.070 |
Why?
|
Seizures | 1 | 2020 | 3000 | 0.070 |
Why?
|
United States | 9 | 2023 | 72903 | 0.070 |
Why?
|
Self Report | 1 | 2019 | 3770 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3956 | 0.070 |
Why?
|
Adolescent | 7 | 2021 | 88835 | 0.070 |
Why?
|
Residential Facilities | 1 | 2007 | 41 | 0.070 |
Why?
|
Radiotherapy | 1 | 1993 | 1494 | 0.070 |
Why?
|
Freedom | 1 | 2007 | 69 | 0.070 |
Why?
|
Age of Onset | 2 | 2015 | 3344 | 0.070 |
Why?
|
Anorexia | 3 | 2013 | 153 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2844 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8529 | 0.070 |
Why?
|
Amyloid beta-Peptides | 1 | 2020 | 3896 | 0.060 |
Why?
|
Massachusetts | 2 | 2023 | 8875 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2015 | 1167 | 0.060 |
Why?
|
Mentors | 2 | 2023 | 671 | 0.060 |
Why?
|
Brain Mapping | 2 | 2021 | 6601 | 0.060 |
Why?
|
Life Style | 1 | 2017 | 3926 | 0.060 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 345 | 0.060 |
Why?
|
Forecasting | 1 | 2014 | 2936 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2009 | 952 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6203 | 0.060 |
Why?
|
Gait Disorders, Neurologic | 1 | 2007 | 246 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2010 | 953 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6322 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3458 | 0.060 |
Why?
|
Self Efficacy | 2 | 2010 | 642 | 0.060 |
Why?
|
Stress, Psychological | 2 | 1993 | 4533 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4958 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4040 | 0.060 |
Why?
|
Schizophrenic Psychology | 1 | 2010 | 1648 | 0.050 |
Why?
|
Protons | 1 | 2008 | 1073 | 0.050 |
Why?
|
Prevalence | 4 | 2024 | 15842 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39193 | 0.050 |
Why?
|
Community Mental Health Services | 1 | 2005 | 381 | 0.050 |
Why?
|
Endocrine System Diseases | 1 | 2024 | 243 | 0.050 |
Why?
|
Databases, Factual | 3 | 2024 | 8067 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2020 | 4628 | 0.050 |
Why?
|
Terminal Care | 1 | 2014 | 1774 | 0.050 |
Why?
|
Control Groups | 1 | 2022 | 106 | 0.050 |
Why?
|
Quality of Life | 3 | 2021 | 13462 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5937 | 0.050 |
Why?
|
Proxy | 1 | 2022 | 151 | 0.050 |
Why?
|
Sleep | 1 | 2017 | 4813 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 326 | 0.040 |
Why?
|
Nursing Homes | 2 | 2020 | 1084 | 0.040 |
Why?
|
Personal Autonomy | 1 | 2023 | 315 | 0.040 |
Why?
|
Professional Competence | 1 | 2004 | 429 | 0.040 |
Why?
|
China | 2 | 2017 | 2385 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2005 | 906 | 0.040 |
Why?
|
Length of Stay | 1 | 2014 | 6485 | 0.040 |
Why?
|
Smoking | 1 | 2017 | 9081 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 605 | 0.040 |
Why?
|
Decision Making | 2 | 2023 | 3965 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 54802 | 0.040 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2019 | 61 | 0.040 |
Why?
|
Ecosystem | 1 | 2023 | 488 | 0.040 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 598 | 0.040 |
Why?
|
Anesthetics | 1 | 2023 | 525 | 0.040 |
Why?
|
Risk Factors | 2 | 2016 | 74840 | 0.040 |
Why?
|
Propofol | 1 | 2023 | 606 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 185 | 0.040 |
Why?
|
Happiness | 1 | 2019 | 173 | 0.040 |
Why?
|
Problem-Based Learning | 1 | 2021 | 360 | 0.040 |
Why?
|
Choice Behavior | 1 | 2023 | 844 | 0.040 |
Why?
|
Macau | 1 | 2016 | 1 | 0.030 |
Why?
|
Social Isolation | 1 | 2020 | 366 | 0.030 |
Why?
|
Videotape Recording | 1 | 1998 | 331 | 0.030 |
Why?
|
Employment | 1 | 2023 | 1106 | 0.030 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2019 | 326 | 0.030 |
Why?
|
Nausea | 2 | 1993 | 680 | 0.030 |
Why?
|
Cohort Studies | 4 | 2022 | 41649 | 0.030 |
Why?
|
Anger | 1 | 2019 | 402 | 0.030 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2020 | 499 | 0.030 |
Why?
|
Vomiting | 2 | 1993 | 647 | 0.030 |
Why?
|
Decision Support Systems, Clinical | 1 | 2005 | 1175 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2019 | 423 | 0.030 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1203 | 0.030 |
Why?
|
Quality Assurance, Health Care | 1 | 2005 | 2172 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 862 | 0.030 |
Why?
|
Quality Improvement | 2 | 2021 | 3853 | 0.030 |
Why?
|
Genomics | 2 | 2021 | 5929 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2022 | 1003 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2020 | 718 | 0.030 |
Why?
|
Standard of Care | 1 | 2019 | 567 | 0.030 |
Why?
|
Homes for the Aged | 1 | 2016 | 273 | 0.030 |
Why?
|
Attitude to Health | 3 | 1998 | 2020 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2022 | 1409 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 856 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2334 | 0.030 |
Why?
|
Reaction Time | 1 | 2020 | 2086 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 838 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2024 | 2098 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 1078 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2411 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
International Cooperation | 1 | 2019 | 1432 | 0.030 |
Why?
|
Fatigue | 2 | 1993 | 1549 | 0.030 |
Why?
|
Clozapine | 1 | 2016 | 509 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20124 | 0.020 |
Why?
|
Resilience, Psychological | 1 | 2020 | 806 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2018 | 962 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1138 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2020 | 1203 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2218 | 0.020 |
Why?
|
Weight Gain | 1 | 2021 | 2355 | 0.020 |
Why?
|
Cholinesterase Inhibitors | 1 | 2013 | 241 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2023 | 1880 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2000 | 1662 | 0.020 |
Why?
|
Neoplasms | 2 | 1993 | 22340 | 0.020 |
Why?
|
Certification | 1 | 2014 | 416 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3141 | 0.020 |
Why?
|
Algorithms | 2 | 2021 | 14071 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1496 | 0.020 |
Why?
|
Accidental Falls | 1 | 2018 | 1078 | 0.020 |
Why?
|
Research | 1 | 1999 | 1975 | 0.020 |
Why?
|
Visual Perception | 1 | 1998 | 1394 | 0.020 |
Why?
|
Fear | 1 | 2019 | 1499 | 0.020 |
Why?
|
Universities | 1 | 2015 | 998 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2140 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 3139 | 0.020 |
Why?
|
Clinical Competence | 2 | 2020 | 4863 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4850 | 0.020 |
Why?
|
Case Management | 1 | 2010 | 277 | 0.020 |
Why?
|
Internet | 1 | 2020 | 3106 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3475 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4159 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9591 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14652 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5446 | 0.020 |
Why?
|
Communication | 1 | 2020 | 3916 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14751 | 0.020 |
Why?
|
Program Evaluation | 1 | 2014 | 2499 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2020 | 4300 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 13024 | 0.010 |
Why?
|
Medicare | 1 | 2023 | 6823 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10729 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15398 | 0.010 |
Why?
|
Time Factors | 2 | 2017 | 40065 | 0.010 |
Why?
|
Social Behavior | 1 | 2010 | 1146 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2010 | 1820 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5508 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7838 | 0.010 |
Why?
|
New England | 1 | 2005 | 1059 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16721 | 0.010 |
Why?
|
Child | 2 | 2019 | 80564 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8923 | 0.010 |
Why?
|
Cost of Illness | 1 | 2010 | 1950 | 0.010 |
Why?
|
Awareness | 1 | 1985 | 653 | 0.010 |
Why?
|
New Hampshire | 1 | 2000 | 174 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29922 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15652 | 0.010 |
Why?
|
Utilization Review | 1 | 2000 | 381 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8626 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24282 | 0.010 |
Why?
|
Patient Admission | 1 | 2000 | 1365 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2005 | 3925 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168764 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2000 | 2778 | 0.000 |
Why?
|
Health Status | 1 | 1998 | 4080 | 0.000 |
Why?
|